e-learning
resources
Virtual 2021
07.09.2021
COPD pharmacology: from basic science to real-world data
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Ten-year projected outcomes associated with increased use of triple therapies in UK patients with COPD using the COPD Health Outcome Policy and INtervention (CHOPIN) model
E. de Nigris (Cambridge, United Kingdom), P. Mcewan (Cardiff, United Kingdom), U. Holmgren (Gothenburg, Sweden), J. Marshall (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), V. Foos (Cardiff, United Kingdom)
Source:
Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Session:
COPD pharmacology: from basic science to real-world data
Session type:
Oral Presentation
Number:
2944
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. de Nigris (Cambridge, United Kingdom), P. Mcewan (Cardiff, United Kingdom), U. Holmgren (Gothenburg, Sweden), J. Marshall (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), V. Foos (Cardiff, United Kingdom). Ten-year projected outcomes associated with increased use of triple therapies in UK patients with COPD using the COPD Health Outcome Policy and INtervention (CHOPIN) model. 2944
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Determinants of long-term changes in ADO prognostic score in UK COPD primary care patients: results from The Health Improvement Network
Source: International Congress 2019 – Powerful cohort studies with/without lung function
Year: 2019
Development of the Birmingham Lung Improvement Studies (BLISS) prognostic score for COPD patients in primary care: data from the Birmingham COPD cohort
Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care
Year: 2019
Projections of 10-year mortality in patients with COPD in the UK using the CHOPIN policy model
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021
The efficacy of COPD patients education: A paired matched case-control study
Source: International Congress 2014 – Best posters in chronic care
Year: 2014
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Mortality predictive factors in COPD patients after a pulmonary rehabilitation programme - a 3 years study
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1
Year: 2014
Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Predictive value of annual costs on 3-year mortality in COPD
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Results of a pulmonary rehabilitation program (PRP) in COPD patients: Differences in outcomes according to currently 2011 GOLD groups
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014
The GOLD COPD categories are inaccurate in predicting future risk in a UK primary care dataset and the 2014 changes to cut-off values have not helped
Source: International Congress 2014 – Respiratory disease management in primary care
Year: 2014
A disease-specific integrated care intervention (ICI) prevents hospital admission only in COPD patients with recurrent hospitalisation
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Drug treatment in a German real-life COPD cohort (DACCORD)
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014
COPD detected with screening: Impact on patient management and prognosis
Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care
Year: 2014
Phenotypes, treatable traits, GOLD groups and grades – how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD)
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020
COPD patients' expectations of ICS/LABA therapy
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014
Validation of the COPD lung cancer screening score in a community based cohort of COPD patients
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Current and future costs of COPD in the Netherlands
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013
Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept